Cancer News and Research

Latest Cancer News and Research

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

NanoSmart Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin.

11 Feb 2015

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.

11 Feb 2015

New article assesses 40 years of intensive effort to improve end-of-life care

After four decades of work - first on patients' rights, then on family and caregiving relationships, and most recently on systemic reform -- we now know that it will take additional efforts in all three areas to improve care at the end of life, concludes an article in the New England Journal of Medicine.

11 Feb 2015

AXT establishes preclinical imaging portfolio with MR solutions product lines

To coincide with the start of Lorne Cancer conference, AXT are proud to announce the commencement of their distributorship with MR SOLUTIONS, a world leader in the development of innovative preclinical imaging solutions

From MR Solutions 11 Feb 2015

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

The Movement Disorder Center at UC San Diego Health System has been designated the 41st Center of Excellence in the National Parkinson Foundation's global network. This competitive designation is the highest recognition offered by NPF to a Parkinson's specialty clinic and represents the consensus of leaders in the field that the multidisciplinary clinic at UC San Diego Health System is among the world's leading centers for Parkinson's research, outreach and care.

11 Feb 2015

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.

11 Feb 2015

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer.

11 Feb 2015

ATA recommends daily serving of iodine in multivitamin/mineral supplements for pregnant, breastfeeding women

The American Thyroid Association has championed the effort to include a daily serving of iodine in multivitamin/mineral supplements intended for pregnant and breastfeeding women, and it applauds the new guidelines released by the U.S. Council for Responsible Nutrition advising manufacturers to include 150 micrograms of iodine to these daily supplements.

11 Feb 2015

Jefferson, RMA of Philadelphia announce clinical partnership

Jefferson announced today its clinical partnership with RMA of Philadelphia, merging the expertise of two outstanding groups of reproductive specialists on its Center City campus.

11 Feb 2015

Research finds that mtDNA can move from healthy cell to dysfunctional tumour cell

Ground-breaking research from Griffith University on the Gold Coast has some scientists wondering if the entire study of cellular biology needs to be adjusted.

11 Feb 2015

OSU researchers discover impact of antibiotics on microorganisms that live in animal's gut

Researchers at Oregon State University have discovered that antibiotics have an impact on the microorganisms that live in an animal's gut that's more broad and complex than previously known.

11 Feb 2015

UT Southwestern leads researchers to establish National Center for Heavy Ion Radiation Therapy

UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.

11 Feb 2015

Freiburg researchers identify novel approach to inhibit signalling processes in colorectal cancer cells

Colorectal carcinoma is the most frequent type of bowel cancer and the second most common tumour disease among men and women in Germany. So-called microsatellite stable colorectal cancer with mutations in the BRAF gene represents a particularly aggressive form.

11 Feb 2015

New type of engineered insulin could improve treatment for diabetes patients

For patients with diabetes, insulin is critical to maintaining good health and normal blood-sugar levels. However, it's not an ideal solution because it can be difficult for patients to determine exactly how much insulin they need to prevent their blood sugar from swinging too high or too low.

11 Feb 2015

Researchers generate new reporter system to study bone regeneration potential of embryonic stem cells

A new reporter system used to study the bone regeneration potential of human embryonic stem cells has been generated in research led by the University of Minnesota. The new reporter system is the first of its kind for human pluripotent stem cells and is important for identifying certain agents and pathways that mediate early stages of human bone development.

11 Feb 2015

REMIND-A-CAP awarded top Innovative Branded Technology honor

REMIND-A-CAP a novel product created to help address the $200 billion challenge of medication non-adherence in the United States, was awarded the top Innovative Branded Technology honor in the recently announced 2014 PM360 Pharma Choice Awards. The customizable and patented pill bottle cap with an ergonomic dial to set for next dosing provides a much-needed tool for companies and brands looking to improve their patient to product adherence.

11 Feb 2015

Study finds higher levels of malignant mesothelioma cases in southern Nevada

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same region carcinogenic mineral fibers including actinolite asbestos, erionite, winchite, magnesioriebeckite and richterite were discovered.

11 Feb 2015

Plain tobacco packaging less effective at prompting smokers to light up

Plain tobacco packaging may reduce the likelihood of smokers seeking to obtain cigarettes by almost 10% compared to branded packs, according to research from the Universities of Exeter and Bristol.

11 Feb 2015

UM one step closer to developing potential drug for treating brain cancer

Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

11 Feb 2015

UNC researchers create new research tool to help crack the histone code

University of North Carolina scientists have created a new research tool, based on the fruit fly, to help crack the histone code. This research tool can be used to better understand the function of histone proteins, which play critical roles in the regulation of gene expression in animals and plants.

11 Feb 2015

Cancer News and Research

Latest Cancer News and Research

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

New article assesses 40 years of intensive effort to improve end-of-life care

AXT establishes preclinical imaging portfolio with MR solutions product lines

Movement Disorder Center at UC San Diego designated Center of Excellence in NPF's global network

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

Oncolytics' REOLYSIN receives FDA Orphan Drug Designation for treatment of ovarian cancer

ATA recommends daily serving of iodine in multivitamin/mineral supplements for pregnant, breastfeeding women

Jefferson, RMA of Philadelphia announce clinical partnership

Research finds that mtDNA can move from healthy cell to dysfunctional tumour cell

OSU researchers discover impact of antibiotics on microorganisms that live in animal's gut

UT Southwestern leads researchers to establish National Center for Heavy Ion Radiation Therapy

Freiburg researchers identify novel approach to inhibit signalling processes in colorectal cancer cells

New type of engineered insulin could improve treatment for diabetes patients

Researchers generate new reporter system to study bone regeneration potential of embryonic stem cells

REMIND-A-CAP awarded top Innovative Branded Technology honor

Study finds higher levels of malignant mesothelioma cases in southern Nevada

Plain tobacco packaging less effective at prompting smokers to light up

UM one step closer to developing potential drug for treating brain cancer

UNC researchers create new research tool to help crack the histone code

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in